High glucose induces podocyte ferroptosis through BAP1/SLC7A11 pathway.

Ren Peiyao, Man Xueli, Sun Wenbo, Zheng Danna, Gong Jianguang, Jin Juan, He Qiang
Author Information
  1. Ren Peiyao: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, PR China.
  2. Man Xueli: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, PR China.
  3. Sun Wenbo: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, PR China.
  4. Zheng Danna: Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, PR China.
  5. Gong Jianguang: Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, PR China.
  6. Jin Juan: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, PR China.
  7. He Qiang: Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, 310000, PR China.

Abstract

Background: Ferroptosis plays an important role in the development of diabetic nephropathy (DN). However, its specific regulatory mechanisms remain unclear.
Methods: MPC5 cells were cultured in high glucose (HG) medium to stimulate the HG environment in vitro. Ferroptosis and oxidative stress were assessed by measuring malondialdehyde (MDA) levels, cystine uptake capacity, and reactive oxygen species (ROS). C91A and wild type (WT) MPC5 cells were constructed to further explore the specific regulatory mechanism of BAP1 on SLC7A11.
Results: Erastin-induced ferroptosis was sensitized by HG, leading to a significant reduction in glutathione (GSH) levels, increased oxidative stress, and inhibited cystine uptake in podocytes. HG suppressed the expression of SLC7A11. Overexpression of SLC7A11 improved cystine uptake and reduced oxidative stress. Furthermore, HG increased BAP1 levels. Silencing BAP1 up-regulated SLC7A11 and mitigated ferroptosis. Cell proliferation was reduced after SLC7A11 knockdown. In BAP1 WT cells, but not in its C91A mutant cells, the transcription of SLC7A11 was downregulated and the level of ferroptosis was increased.
Conclusion: HG inhibits cystine uptake in podocytes by promoting the expression of BAP1 and inhibiting H2Aub deubiquitination on SLC7A11, leading to lipid peroxide accumulation and ferroptosis in podocytes.

Keywords

References

  1. Front Immunol. 2023 Jul 21;14:1185317 [PMID: 37545494]
  2. Mol Cell. 2022 Jun 16;82(12):2215-2227 [PMID: 35390277]
  3. Diabetes Res Clin Pract. 2019 Nov;157:107843 [PMID: 31518657]
  4. Cancer Discov. 2020 Aug;10(8):1103-1120 [PMID: 32690542]
  5. Nat Rev Mol Cell Biol. 2021 Apr;22(4):266-282 [PMID: 33495651]
  6. Int J Mol Sci. 2023 Aug 03;24(15): [PMID: 37569752]
  7. Cell Cycle. 2019 Apr;18(8):773-783 [PMID: 30907299]
  8. Cell Death Differ. 2021 Feb;28(2):606-625 [PMID: 33462414]
  9. J Adv Res. 2020 Jul 22;28:231-243 [PMID: 33364059]
  10. Protein Cell. 2021 Aug;12(8):599-620 [PMID: 33000412]
  11. Int J Biol Sci. 2023 Jul 16;19(12):3726-3743 [PMID: 37564215]
  12. Nat Cell Biol. 2018 Oct;20(10):1181-1192 [PMID: 30202049]
  13. Biomed Pharmacother. 2023 Aug;164:114897 [PMID: 37224754]
  14. Antioxidants (Basel). 2022 Dec 11;11(12): [PMID: 36552652]
  15. Front Immunol. 2023 Dec 04;14:1294317 [PMID: 38111578]
  16. Antioxid Redox Signal. 2016 Oct 20;25(12):657-684 [PMID: 26906673]
  17. Nat Rev Mol Cell Biol. 2024 Feb;25(2):133-155 [PMID: 37783783]
  18. J Diabetes Res. 2017;2017:2615286 [PMID: 28791309]
  19. Int J Mol Sci. 2021 Oct 07;22(19): [PMID: 34639176]
  20. Diabetes. 2002 Aug;51(8):2348-54 [PMID: 12145144]
  21. Cells. 2022 Feb 05;11(3): [PMID: 35159361]
  22. J Transl Med. 2021 Aug 26;19(1):367 [PMID: 34446045]
  23. Trends Cell Biol. 2016 Mar;26(3):165-176 [PMID: 26653790]
  24. Trends Biochem Sci. 2016 Mar;41(3):274-286 [PMID: 26725301]
  25. Cell Res. 2021 Feb;31(2):107-125 [PMID: 33268902]
  26. Cancer Res. 2021 Jun 1;81(11):2807-2814 [PMID: 33446574]
  27. Signal Transduct Target Ther. 2023 Sep 21;8(1):372 [PMID: 37735472]
  28. Am J Kidney Dis. 2018 Jun;71(6):884-895 [PMID: 29398179]
  29. Free Radic Biol Med. 2021 Jan;162:435-449 [PMID: 33152439]
  30. Diabetes Metab. 2019 Jun;45(3):286-293 [PMID: 30196138]
  31. Cardiovasc Diabetol. 2023 Sep 2;22(1):237 [PMID: 37660030]

Word Cloud

Created with Highcharts 10.0.0SLC7A11HGBAP1ferroptosiscellscystineuptakeFerroptosisoxidativestresslevelsincreasedpodocytesnephropathyspecificregulatoryMPC5glucoseC91AWTleadingexpressionreducedBackground:playsimportantroledevelopmentdiabeticDNHowevermechanismsremainunclearMethods:culturedhighmediumstimulateenvironmentvitroassessedmeasuringmalondialdehydeMDAcapacityreactiveoxygenspeciesROSwildtypeconstructedexploremechanismResults:Erastin-inducedsensitizedsignificantreductionglutathioneGSHinhibitedsuppressedOverexpressionimprovedFurthermoreSilencingup-regulatedmitigatedCellproliferationknockdownmutanttranscriptiondownregulatedlevelConclusion:inhibitspromotinginhibitingH2AubdeubiquitinationlipidperoxideaccumulationHighinducespodocyteBAP1/SLC7A11pathwayDiabeticUbiquitination

Similar Articles

Cited By